Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer

JOURNAL ARTICLE published 10 March 2022 in New England Journal of Medicine

Research funded by Novartis Pharmaceuticals Corporation (N/A)

Authors: Gabriel N. Hortobagyi | Salomon M. Stemmer | Howard A. Burris | Yoon-Sim Yap | Gabe S. Sonke | Lowell Hart | Mario Campone | Katarina Petrakova | Eric P. Winer | Wolfgang Janni | Pierfranco Conte | David A. Cameron | Fabrice André | Carlos L. Arteaga | Juan P. Zarate | Arunava Chakravartty | Tetiana Taran | Fabienne Le Gac | Paolo Serra | Joyce O’Shaughnessy